Emerging countries press for Covid-19 vaccine supply in poor nations
- The joint statement by the so-called "BRICS" group -- Brazil, Russia, India, China and South Africa -- followed an online summit chaired by India's Foreign Minister Subrahmanyam Jaishankar.
Five of the world's biggest emerging economies Tuesday called for the development and delivery of Covid-19 vaccines to be sped up, reiterating that measures such as waiving intellectual property rights over jabs could help poorer nations battle the pandemic.
The joint statement by the so-called "BRICS" group -- Brazil, Russia, India, China and South Africa -- followed an online summit chaired by India's Foreign Minister Subrahmanyam Jaishankar.
The foreign ministers said "extensive immunisation" would help bring the pandemic to an end, highlighting the "urgency for expeditious development and deployment of Covid-19 vaccines, especially in developing countries".
They also expressed support for the global campaign led by South Africa and India at the World Trade Organization to temporarily waive IP rights for Covid-19 vaccines.
Sharing vaccine doses, technology transfers, developing local production and supply chains as well as price transparency would also boost the fight against the infectious disease, the statement added.
South Africa's Foreign Minister Naledi Pandor earlier Tuesday reiterated Pretoria's position that "none of us are safe until all of us are safe".
Securing a waiver agreement "will allow use of intellectual property, the sharing of technologies and technology transfer," Pandor told the BRICS meeting, enabling "the production of vaccine therapeutics and wider distribution".
Supporters of the move argue it will spur production of low-cost generic vaccines, helping poor countries that are struggling to immunise their people.
The US under President Joe Biden has thrown its weight behind the bid alongside China, but other pharmaceutical heavyweights including the EU, Britain and Japan are reluctant.
Opponents argue waiving patents will damage intellectual property rights and erode the profit incentive, ultimately affecting pharmaceutical research and development.
Pharmaceutical companies also point out that manufacturing a vaccine requires know-how and technical resources which cannot be acquired at the flip of a switch.
Pandor, speaking by video link from Pretoria, said "millions of people in wealthier nations have been vaccinated, while billions of people in poorer countries still wait and are still vulnerable to infection, disease and death".
Just two percent of global vaccines have been administered in sub-Saharan Africa, according to WHO figures -- a situation that Pandor described as a "global gap of vaccine access".
Sixty-three countries have backed the Indian-South African proposal, but unanimity among all 164 WTO member states is needed for agreement.